STOCK TITAN

Butterfly Network Inc - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Overview

Butterfly Network Inc (symbol: BFLY) stands at the forefront of digital health by revolutionizing medical imaging through its innovative handheld ultrasound technology. Combining expertise in digital health, medical imaging, and handheld ultrasound systems, the company is dedicated to democratizing access to diagnostic imaging. By leveraging semiconductor technology and cloud-connected systems, Butterfly Network delivers solutions that are not only affordable and portable but also integrate intelligently into clinical workflows.

Cutting-Edge Technology

The foundation of Butterfly Network’s revolutionary products lies in its proprietary Ultrasound-on-Chip technology. This state-of-the-art semiconductor approach enables the production of a single handheld probe capable of whole-body imaging. The technology fundamentally transforms how ultrasound is applied in both routine and emergent care by replacing bulky, expensive ultrasound machines with a compact, easy-to-use device. The intelligent integration with a mobile application and cloud-connected software further enriches its usability, providing healthcare professionals with instant access to imaging data and remote guidance when needed.

Innovative Business Model and Market Position

Butterfly Network’s business model is markedly different from traditional medical device companies. The company focuses almost exclusively on product and intellectual property development, backed by a group of successful serial entrepreneurs. This unique approach allows for uninterrupted innovation and rapid iteration of its technology portfolio. Butterfly Network generates revenue primarily through the direct sales of its ultrasound devices and ancillary services such as software updates and educational tools. Its low-cost, high-performance products have redefined market expectations and disrupted the conventional imaging space.

Integration of AI and Cloud Connectivity

One of the hallmarks of Butterfly Network’s strategy is the seamless integration of artificial intelligence (AI) into its products. The incorporation of AI-driven applications, such as the ScanLab™ education tool, dramatically enhances the clinical utility of its devices. This AI-guided educational approach provides users with real-time anatomical labels, step-by-step instructions, and performance feedback. The intelligent software not only helps improve scanning proficiency among healthcare practitioners but also supports independent learning, making Butterfly Network an essential partner in modern medical education and clinical practice.

Transforming Medical Education and Clinical Training

Butterfly Network has played a pivotal role in elevating point-of-care ultrasound (POCUS) training. The company collaborates with leading academic institutions such as Kansas City University to integrate its AI-powered ScanLab™ into medical curricula. This initiative enables medical students to gain hands-on experience that is critical to their development as proficient clinicians. By offering a robust, interactive training platform, Butterfly Network ensures that upcoming healthcare professionals are well-versed in modern imaging techniques before entering residency or clinical practice.

Impact on Patient Care and Clinical Workflows

The combination of affordability, portability, and ease-of-use brings ultrasound imaging directly to the point-of-care. Healthcare providers can now perform real-time, whole-body imaging with devices that fit in their pockets. This capability not only enhances diagnostic speed and accuracy but also increases patient engagement by facilitating timely and precise treatment decisions. Butterfly Network’s solution removes the traditional barriers of cost and accessibility, enabling high-quality imaging in diverse settings ranging from urban hospitals to rural clinics and emergency scenarios.

Competitive Landscape and Industry Differentiation

Within the rapidly evolving digital health market, Butterfly Network distinguishes itself by integrating advanced semiconductor technology with intelligent software. While other companies in the medical imaging space may offer traditional ultrasound systems, Butterfly Network’s single-probe solution is unique in its capacity to deliver full-body imaging through a device that is both highly portable and cost-effective. This distinctive product offering not only serves a broad spectrum of clinical applications, including diagnostics in emergent and non-emergent scenarios, but also caters to veterinary medicine and other niche verticals. The emphasis on continuous product innovation and educational support further solidifies its standing among innovators in the field.

Collaboration and Ecosystem Development

Butterfly Network has cultivated a robust ecosystem that spans multiple disciplines, including computer science, physics, and electrical engineering. By drawing on diverse expertise, the company fosters an environment dedicated to continuous technological advancement and innovation. Its strategic partnerships with academic institutions, healthcare organizations, and industry innovators enhance its ability to refine and adapt its offerings to the evolving needs of the healthcare market. In addition, its educational initiatives and collaborative projects have built a network that not only supports clinical practice but also accelerates the adoption of new imaging technologies across global markets.

Comprehensive Approach to Digital Health

At the intersection of medical imaging and digital health, Butterfly Network is committed to both technological innovation and clinical excellence. Its portfolio merges hardware innovation with intelligent, cloud-enabled solutions, ensuring that every product released under its name delivers tangible benefits to healthcare professionals and patients alike. The company also emphasizes education and training as core components of its mission, ensuring that users are equipped to maximize the potential of its technology.

Commitment to Quality and User-Centric Design

Every aspect of Butterfly Network’s product development is underscored by a commitment to quality and usability. The devices are designed with the end-user in mind, enabling straightforward integration into existing clinical workflows and enhancing diagnostic efficacy without compromising on reliability. This pragmatic focus on user experience is reflected in the simple, intuitive interfaces and comprehensive support systems that accompany each product. Moreover, the continuous feedback loop from clinical educators and frontline practitioners helps refine the technology, ensuring it meets the high demands of modern healthcare environments.

Conclusion

Butterfly Network Inc is redefining the landscape of medical imaging with its innovative, handheld ultrasound solutions. Its integration of sophisticated semiconductor technology, AI-driven educational tools, and cloud-connected software creates a unique value proposition that transforms clinical practice and medical training. Through continuous collaboration with academic and healthcare institutions, the company is not only making high-quality ultrasound accessible but is also paving the way for the future of digital health. Its approach embodies a perfect blend of technological ingenuity and clinical pragmatism, making it a significant and enduring player in the field of medical imaging.

Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the TD Cowen 44th Annual Health Care Conference in Boston on March 5, 2024. Joseph DeVivo and Heather Getz will present the company's handheld ultrasound technology and software. Investors can schedule one-on-one meetings with the executives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) will host an Investor Day on March 18, 2024, at the New York Stock Exchange. The event will showcase their product portfolio, strategic initiatives, and new Butterfly iQ3™. Key executives will present, along with strategic partners introducing AI tools and products in development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will report Q4 and full year 2023 financial results on February 28, 2024. An Investor Day is scheduled for March 18, 2024, at the New York Stock Exchange, showcasing the latest ultrasound technology and co-developed products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.19%
Tags
conferences earnings
Rhea-AI Summary
Butterfly Network, Inc. launches Butterfly iQ3, a third-generation handheld point-of-care ultrasound system powered by advanced semiconductor chip technology. The device offers unparalleled image quality, faster micro-beamforming, and new 3D imaging capabilities. Butterfly iQ3 is available for purchase in the United States at $3,899 plus membership, aiming to revolutionize point-of-care ultrasound with enhanced comfort, efficiency, and innovative tools.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.08%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) expects to exceed 2023 revenue and adjusted EBITDA guidance. The company showcased the sharp image quality of its newly FDA-cleared, third-generation probe, Butterfly iQ3, and introduced iQ Slice, the world’s first automated, sequential image capture mode on a handheld ultrasound, launching with Butterfly iQ3. Joseph DeVivo, Butterfly Network’s President, CEO, and Chairman, expressed confidence in the team's performance and energy, leading to the expectation of exceeding the 2023 guidance provided. The company’s previously issued guidance for the full year 2023 was revenue of at least $64 million, and an improved adjusted EBITDA loss of $75 - 70 million. Butterfly also announced FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3, and expects to launch it this quarter (Q1 2024).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announces FDA clearance for Butterfly iQ3, a next-generation handheld point-of-care ultrasound system. The new device features advanced semiconductor technology, improved image resolution, sensitivity, and penetration, as well as faster 3D capabilities. It also introduces novel, automated image capture modes: iQ Slice and iQ Fan. Butterfly iQ3 is set to revolutionize digital ultrasound and make it more accessible and approachable than ever before.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.79%
Tags
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. The company is a digital health company specializing in handheld, whole-body ultrasound and intuitive software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) and Mendaera partner to bring Butterfly’s Ultrasound-on-Chip™ to the robotic intervention market, with revenue anticipated from every unit sold. The partnership aims to streamline patient care by improving precision and consistency for a broad range of image-guided, needle-based interventions. FDA submission of the product is anticipated by 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.13%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-11, 2024, in San Francisco. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on January 11, 2024, at 9:00 AM PST. A webcast of the presentation will be available on the Butterfly investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate at the Jefferies London Healthcare Conference on November 14-16, 2023. CEO Joseph DeVivo and CFO Heather Getz will present on November 14 at 3:30 PM GMT. A live webcast will be available on the Butterfly Network investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $2.34 as of April 18, 2025.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 597.6M.

What is Butterfly Network's core technology?

Butterfly Network utilizes proprietary Ultrasound-on-Chip technology to deliver handheld, whole-body ultrasound imaging. This semiconductor-based approach enables compact, affordable, and high-performance medical imaging.

How does Butterfly Network generate revenue?

The company primarily generates revenue through the direct sales of its ultrasound devices and complementary services, including software and educational tools that support clinical training and practice.

What makes Butterfly Network's ultrasound technology unique?

Its unique integration of semiconductor technology with cloud-connected, AI-powered software allows a single handheld device to deliver high-quality, full-body imaging that is both accessible and easy to use in various clinical settings.

How is Butterfly Network positioned within the digital health market?

Butterfly Network differentiates itself by focusing solely on product and intellectual property development, leveraging advanced technology and strategic partnerships to revolutionize medical imaging and point-of-care diagnostics.

What role does AI play in Butterfly Network's solutions?

AI is integral to the company’s offerings, enhancing clinical workflows through real-time scanning guidance, anatomical labeling, and performance feedback via tools like the ScanLab™ application, which improves both user proficiency and diagnostic accuracy.

How does Butterfly Network support medical education?

The company collaborates with educational institutions to integrate its handheld ultrasound and AI-driven training tools into medical curricula, enabling students to gain practical, hands-on experience that prepares them for clinical practice.

Who are Butterfly Network's main competitors in the market?

While several companies operate within the medical imaging space, Butterfly Network distinguishes itself by combining advanced semiconductor technology with AI and cloud connectivity, setting it apart from traditional ultrasound providers.

What market segments does Butterfly Network serve?

Butterfly Network serves a broad spectrum of market segments including clinical diagnostics, point-of-care assessments, medical education, and even veterinary applications, ensuring its technology is applicable across diverse healthcare settings.
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

597.59M
184.42M
14.88%
29.79%
5.07%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON